NCT05132465

Brief Summary

What research question is being addressed? Can improve the prediction of adverse outcomes be improved for people following a stroke to optimise their treatment and care? How is it of relevance and importance to patients and public? Following a stroke, people are at a higher risk of developing certain conditions including heart failure, another stroke and atrial fibrillation, a type of irregular heart rhythm. In the proposed study, the investigators will look at factors which may increase a person's risk of such conditions following stroke. From this, the investigators will determine if risk scores for these conditions can be improved for people post-stroke. This could help doctors decide what treatments are best. Who would be eligible? All adults at participating hospitals who have had an ischaemic stroke (where the stroke is caused by loss of blood flow to the brain) or a transient ischaemic attack ('mini-stroke') confirmed by a stroke doctor. All patients will be asked to take part in the study, or their family members may be asked to provide advice on their behalf if the patient is unable to. Where is the study being conducted? At participating hospitals in England and Wales. What will the participants undergo? At the time of stroke, patients have a lot of information collected about their health, the investigators will copy information from patient's medical records about their health after they agree to take part in the study. Patients or their family members will also be asked to complete some additional brief questionnaires about their quality of life, wellbeing and fatigue. Some questionnaires such as for cognitive function are already collected for patients following a stroke, but where this information has not been collected, it will be collected for the study. The investigators will ask the patients if they can be contacted in 12-months to repeat the questionnaires and information collected about their health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,655

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 12, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 24, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2024

Completed
Last Updated

February 21, 2025

Status Verified

March 1, 2024

Enrollment Period

2.7 years

First QC Date

November 12, 2021

Last Update Submit

February 19, 2025

Conditions

Keywords

strokeobservational study

Outcome Measures

Primary Outcomes (4)

  • Number of participants with incident stroke, transient ischaemic attack, atrial fibrillation, myocardial infarction and heart failure

    Incident stroke, transient ischaemic attack, atrial fibrillation, myocardial infarction and heart failure

    12 months

  • Mortality

    All-cause mortality and mortality from cardiovascular causes

    12 months

  • Number of participants with incident cognitive impairment

    Cognitive impairment determined from Montreal Cognitive Assessment (MoCA) test results

    12 months

  • Number of participants with incident dementia

    Dementia determined from clinical diagnosis

    12 months

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients from participating hospitals with a recent ischaemic stroke confirmed by stroke physician or transient ischaemic attack confirmed by MRI are eligible unless they are received palliative or end-of-life care. This study aims to be as inclusive as possible with recruitment and provide methods for advice to be sought from a personal consultee (relative/friend/carer) where informed consent is not possible in line with the Mental Capacity Act 2005.

You may qualify if:

  • ≥18 years old
  • Current in-patient at a participating hospital the time of baseline data collection for recent ischaemic stroke confirmed by stroke physician or transient ischaemic attack confirmed by magnetic resonance imaging (MRI)

You may not qualify if:

  • Inability to provide informed consent and no personal consultee available or personal consultee does not think the person would want to participate
  • Receiving palliative or end-of-life care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Countess of Chester Hospital

Chester, CH2 1UL, United Kingdom

Location

Related Publications (1)

  • Harrison SL, Lane DA, Buckley BJR, Chatterjee K, Alobaida M, Shipley E, Lip GYH. The Liverpool Heart And bRain Project (L-HARP): Protocol for an Observational Cohort Study of Cardiovascular Risk and Outcomes Following Stroke. Vasc Health Risk Manag. 2022 Apr 26;18:313-318. doi: 10.2147/VHRM.S357829. eCollection 2022.

MeSH Terms

Conditions

Ischemic StrokeIschemic Attack, TransientStroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBrain Ischemia

Study Officials

  • Stephanie L Harrison, PhD

    University of Liverpool

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2021

First Posted

November 24, 2021

Study Start

October 12, 2021

Primary Completion

June 10, 2024

Study Completion

June 10, 2024

Last Updated

February 21, 2025

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations